Zevra Therapeutics (ZVRA) Acquisitions (2022 - 2023)
Zevra Therapeutics (ZVRA) reported Acquisitions of $30.4 million for Q4 2023, up 115.98% quarter-over-quarter from $14.1 million in Q3 2022.
Zevra Therapeutics (ZVRA) Acquisitions (2022 - 2023) Analysis & Trends
Zevra Therapeutics has reported Acquisitions for 2 years, with the latest figure at $30.4 million in Q4 2023.
- For the quarter ending Q4 2023, Acquisitions changed N/A year-over-year to $30.4 million; the trailing twelve-month figure through Dec 2023 stood at $44.5 million (up 215.98% YoY), and the FY2023 full-year result was $30.4 million, up 115.76% from the prior year.
- Acquisitions for Q4 2023 stood at $30.4 million, up from $14.1 million in the prior quarter.
- The five-year high for Acquisitions was $30.4 million in Q4 2023, with the low at $14.1 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Zevra Therapeutics | 704.96 Mn | 504.34 Mn | 34.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 30.40 Mn |
| Sep 30, 2022 | 14.08 Mn |